Furthermore, gain-of-function mutations of Orai1 and STIM1 gave rise to tubular aggregate myopathy (TAM) and Stormorken syndrome (STRMK), forming a clinical spectrum encompassing muscle weakness, myalgia, and cramps, and additional multi-systemic signs, including short stature [106]. This evidence concerns the gene STIM1 and Stormorken syndrome.